GlassScriptPhysician profile
Matthew D Mcguffee
NPI 1407348352
$4,711.64
in general payments reported to CMS, 2019-2025
27 companies · $819 in 2025
The $819 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $700 · 2022: $1,228 · 2023: $1,134 · 2024: $831 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,783.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,004.73 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $662.98 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $519.43 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $411.73 | 2021-2023 | Xarelto |
| Amgen INC. | $410.34 | 2021-2025 | Repatha, Repatha |
| Abbott Laboratories | $260.97 | 2022-2025 | Aveir |
| Itamar Medical INC | $180.19 | 2023 | Watchpatone |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.38 | 2021-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $151.49 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $119.25 | 2021-2024 | |
| Pfizer INC. | $114.72 | 2021-2024 | |
| Esperion Therapeutics, INC. | $104.35 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $73.05 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $71.67 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.37 | 2023-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $60.45 | 2024-2025 | Wegovy |
| Irhythm Technologies, INC. | $52.48 | 2023 | Zio Xt Patch |
| Inspire Medical Systems, INC. | $50.82 | 2025 | Inspire |
| Kiniksa Pharmaceuticals, LTD. | $50.56 | 2023 | Arcalyst |
| Abiomed | $41.31 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $26.58 | 2021 | |
| Stryker Corporation | $22.91 | 2025 | Clottriever Bold Catheter |
| Philips North America LLC | $22.69 | 2025 | Lm Undivided |
| Actelion Pharmaceuticals US, INC. | $20.69 | 2022 | |
| Medtronic, INC. | $19.14 | 2021 | |
| Alnylam Pharmaceuticals INC. | $16.56 | 2025 | Amvuttra |
| Zoll Circulation INC | $5.80 | 2023 | Catheter, Downstream Cartridge, Therox Ds2 Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mcguffee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.